These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 39329726)

  • 1. Human Multi-Lineage Liver Organoid Model Reveals Impairment of CYP3A4 Expression upon Repeated Exposure to Graphene Oxide.
    Romaldini A; Spanò R; Veronesi M; Grimaldi B; Bandiera T; Sabella S
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Generation of Functional Liver Organoid-Like Structures Using Adult Human Cells.
    Ramachandran SD; Schirmer K; Münst B; Heinz S; Ghafoory S; Wölfl S; Simon-Keller K; Marx A; Øie CI; Ebert MP; Walles H; Braspenning J; Breitkopf-Heinlein K
    PLoS One; 2015; 10(10):e0139345. PubMed ID: 26488607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation & characterization of expandable human liver sinusoidal endothelial cells and their application to assess hepatotoxicity in an advanced in vitro liver model.
    Kaden T; Noerenberg A; Boldt J; Sagawe C; Johannssen T; Rennert K; Raasch M; Evenburg T
    Toxicology; 2023 Jan; 483():153374. PubMed ID: 36396002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral nutrition emulsion inhibits CYP3A4 in an iPSC derived liver organoids testing platform.
    Harrison SP; Baumgarten SF; Chollet ME; Stavik B; Bhattacharya A; Almaas R; Sullivan GJ
    J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1047-1058. PubMed ID: 38529852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-Lethal Concentrations of Graphene Oxide Trigger Acute-Phase Response and Impairment of Phase-I Xenobiotic Metabolism in Upcyte
    Romaldini A; Spanò R; Catalano F; Villa F; Poggi A; Sabella S
    Front Bioeng Biotechnol; 2022; 10():867728. PubMed ID: 35662849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
    Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
    Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient hepatocyte differentiation of primary human hepatocyte-derived organoids using three dimensional nanofibers (HYDROX) and their possible application in hepatotoxicity research.
    Tong Y; Ueyama-Toba Y; Yokota J; Matsui H; Kanai M; Mizuguchi H
    Sci Rep; 2024 May; 14(1):10846. PubMed ID: 38736008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids.
    Mun SJ; Lee J; Chung KS; Son MY; Son MJ
    Cells; 2021 Jan; 10(1):. PubMed ID: 33440728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
    Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
    Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of human liver organoids from pluripotent stem cell-derived hepatic endoderms.
    Kulkeaw K; Tubsuwan A; Tongkrajang N; Whangviboonkij N
    PeerJ; 2020; 8():e9968. PubMed ID: 33133779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-Specific Microparticles Improve Organoid Microenvironment for Efficient Maturation of Pluripotent Stem-Cell-Derived Hepatocytes.
    Zahmatkesh E; Ghanian MH; Zarkesh I; Farzaneh Z; Halvaei M; Heydari Z; Moeinvaziri F; Othman A; Ruoß M; Piryaei A; Gramignoli R; Yakhkeshi S; Nüssler A; Najimi M; Baharvand H; Vosough M
    Cells; 2021 May; 10(6):. PubMed ID: 34063948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructures of diamond, graphene oxide and graphite inhibit CYP1A2, CYP2D6 and CYP3A4 enzymes and downregulate their genes in liver cells.
    Strojny B; Sawosz E; Grodzik M; Jaworski S; Szczepaniak J; Sosnowska M; Wierzbicki M; Kutwin M; Orlińska S; Chwalibog A
    Int J Nanomedicine; 2018; 13():8561-8575. PubMed ID: 30587978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional 3D Human Liver Bud Assembled from MSC-Derived Multiple Liver Cell Lineages.
    Li J; Xing F; Chen F; He L; So KF; Liu Y; Xiao J
    Cell Transplant; 2019 May; 28(5):510-521. PubMed ID: 29895168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-dimensional multiwell cell culture method for the production of CYP3A4-expressing hepatocyte-like cells from HepaRG cells.
    Ooeda K; Kubiura-Ichimaru M; Tsuji S; Okuyama S; Yamashita M; Mine A; Kawamura F; Ueyama T; Tada M
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00652. PubMed ID: 32955797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
    Utkarsh D; Loretz C; Li AP
    Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Fe
    Foroutan T; Kassaee MZ; Salari M; Ahmady F; Molavi F; Moayer F
    Cell Prolif; 2021 Nov; 54(11):e13126. PubMed ID: 34569673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Highly Functional Hepatocyte-like Organoids from Human Adipose-Derived Mesenchymal Stem Cells Cultured with Endothelial Cells.
    Chen S; Saito Y; Waki Y; Ikemoto T; Teraoku H; Yamada S; Morine Y; Shimada M
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized 3D Culture of Hepatic Cells for Liver Organoid Metabolic Assays.
    Gamboa CM; Wang Y; Xu H; Kalemba K; Wondisford FE; Sabaawy HE
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary glycation compounds - implications for human health.
    Hellwig M; Diel P; Eisenbrand G; Grune T; Guth S; Henle T; Humpf HU; Joost HG; Marko D; Raupbach J; Roth A; Vieths S; Mally A
    Crit Rev Toxicol; 2024 Sep; 54(8):485-617. PubMed ID: 39150724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.